Jessie Correa
Family · Bessemer, ALNPI 1093202889
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.7% of the total across 641 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 23.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $3,672 and has fallen 79.8% since, to $741 in 2025. Among family clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 641 payments — averaging $19.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- Johnson & Johnson$1K
- Intercept Pharmaceuticals, Inc.$901
- Phathom Pharmaceuticals, Inc.$609
- Gilead$593
- plus $4K from 29 others
What the payments were for
- Food & beverage$11,92897%
- Education$4083%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 131 | $2,845 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 160 | $2,129 |
| Johnson & Johnson(2 entities) | 64 | $1,435 |
| Intercept Pharmaceuticals, Inc. | 35 | $901 |
| Phathom Pharmaceuticals, Inc. | 10 | $609 |
| Gilead | 23 | $593 |
| Redhill Biopharma Inc. | 55 | $577 |
| Ardelyx, Inc. | 34 | $465 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $363 |
| Janssen Scientific Affairs, LLC | 4 | $297 |
| Aimmune Therapeutics, Inc. | 5 | $296 |
| Nestle Healthcare Nutrition Inc. | 20 | $254 |
| Bristol Myers Squibb | 14 | $230 |
| Vivus LLC | 10 | $163 |
| Ipsen Biopharmaceuticals, Inc | 6 | $145 |
| Celltrion USA Inc. | 7 | $139 |
| QOL Medical, LLC | 4 | $112 |
| Ferring Pharmaceuticals Inc. | 5 | $89 |
| Lilly USA, LLC | 4 | $82 |
| Daiichi Sankyo Inc. | 4 | $79 |
| Madrigal Pharmaceuticals | 3 | $72 |
| Sanofi | 3 | $67 |
| Ironwood Pharmaceuticals, Inc | 4 | $61 |
| Evoke Pharma, Inc. | 3 | $53 |
| Braintree Laboratories, Inc. | 3 | $45 |
| Novo Nordisk | 2 | $38 |
| Merck | 2 | $36 |
| Alnylam Pharmaceuticals Inc. | 1 | $29 |
| Pfizer | 2 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Exact Sciences | 1 | $18 |
| Medtronic | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Alfasigma USA, Inc. | 1 | $16 |
| Mallinckrodt Hospital Products Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,336 in reported general payments places this provider in the 95th percentile of 3,415 family providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SutabSod Sulf/Pot Chloride/Mag Sulf | 69 | $11,210 |
| LinzessLinaclotide | 14 | $11,135 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 50 | $8,450 |
| Dexlansoprazole DrDexlansoprazole | 11 | $2,792 |
| Dicyclomine Hcl | 88 | $2,019 |
| PlenvuPeg3350/Sod Sul/Nacl/Kcl/Asb/C | 12 | $1,664 |
| Omeprazole | 68 | $1,107 |
| Pantoprazole Sodium | 94 | $406 |
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 14 | $335 |
| Famotidine | 28 | $322 |
| Hydrocortisone | 13 | $153 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 14 | $140 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Braintree Laboratories, Inc.Sutab | $45 | $11,21069 claims |
| AbbVieLinzess | $2,845 | $11,13514 claims |
| Ferring Pharmaceuticals Inc.Clenpiq | $89 | $8,45050 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCPlenvu | $2,129 | $1,66412 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,415 family providers in Alabama.
Other family in Bessemer
- Leigh Ann ChildressHuntsville$240K
- Molly ReevesAuburn$158K
- Christina CanteyHuntsville$118K
- Leigh LunaMontgomery$69K
- Christopher LovellMobile$64K
- Justin SimpsonTuscaloosa$43K
- Kellyn McMahonBirmingham$39K
- Ashley StinesTuscaloosa$29K
- Brandy YoungMontgomery$27K
- Julia BettsHuntsville$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.